Chronic glucokinase activator treatment activates liver Carbohydrate response element binding protein and improves hepatocyte ATP homeostasis during substrate challenge.

Diabetes, Obesity & Metabolism
Brian E FordL Agius

Abstract

To test the hypothesis that glucokinase activators (GKAs) induce hepatic adaptations that alter intra-hepatocyte metabolite homeostasis. C57BL/6 mice on a standard rodent diet were treated with a GKA (AZD1656) acutely or chronically. Hepatocytes were isolated from the mice after 4 or 8 weeks of treatment for analysis of cellular metabolites and gene expression in response to substrate challenge. Acute exposure of mice to AZD1656 or a liver-selective GKA (PF-04991532), before a glucose tolerance test, or challenge of mouse hepatocytes with GKAs ex vivo induced various Carbohydrate response element binding protein (ChREBP) target genes, including Carbohydrate response element binding protein beta isoform (ChREBP-β), Gckr and G6pc. Both glucokinase activation and ChREBP target gene induction by PF-04991532 were dependent on the chirality of the molecule, confirming a mechanism linked to glucokinase activation. Hepatocytes from mice treated with AZD1656 for 4 or 8 weeks had lower basal glucose 6-phosphate levels and improved ATP homeostasis during high substrate challenge. They also had raised basal ChREBP-β mRNA and AMPK-α mRNA (Prkaa1, Prkaa2) and progressively attenuated substrate induction of some ChREBP target genes and Prkaa1...Continue Reading

References

Sep 1, 1970·The Biochemical Journal·H F WoodsH A Krebs
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Jun 1, 1973·The Biochemical Journal·H F Woods, H A Krebs
Aug 4, 2006·The Journal of Biological Chemistry·Lin MaHoward C Towle
Dec 16, 2010·Expert Opinion on Therapeutic Patents·Ramakanth SarabuJefferson W Tilley
May 19, 2011·European Journal of Pharmacology·Maria Sörhede WinzellBo Ahrén
Jun 23, 2012·The Journal of Clinical Endocrinology and Metabolism·Ensio NorjavaaraMarcus Hompesch
Jul 20, 2012·Journal of Medicinal Chemistry·Ramakanth SarabuJoseph Grimsby
Jan 12, 2013·Trends in Pharmacological Sciences·Franz M Matschinsky
May 14, 2014·Expert Opinion on Therapeutic Patents·Kevin J Filipski, Jeffrey A Pfefferkorn
Oct 1, 2014·Expert Opinion on Therapeutic Patents·Loranne Agius
Mar 25, 2015·Journal of Diabetes Investigation·Akinobu Nakamura, Yasuo Terauchi
Oct 4, 2015·Trends in Molecular Medicine·Martijn C G J BrouwersNicolaas C Schaper
May 6, 2016·Annual Review of Nutrition·Loranne Agius
Nov 2, 2016·The Journal of Clinical Investigation·Mi-Sung KimMark A Herman
Feb 17, 2017·Diabetes, Obesity & Metabolism·Ziad H Al-OanziLoranne Agius
Feb 9, 2018·Nature Communications·Davide BascoBernard Thorens
Jan 25, 2020·The Journal of Biological Chemistry·Tabassum MooniraLoranne Agius
May 8, 2020·International Journal of Molecular Sciences·Loranne AgiusShruti S Chachra

❮ Previous
Next ❯

Citations

Jun 10, 2021·Diabetes, Obesity & Metabolism·Akinobu NakamuraYasuo Terauchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.